- Penny Sleuth - http://pennysleuth.com -
This Small Medical Waste Company Offers Growth Right Now
Posted By Steve Alexander On February 11, 2010 @ 11:20 am In Featured,Penny stocks | 1 Comment
Forget the likes of Google (NASDAQ: GOOG ) and Apple (NASDAQ: AAPL ) – sometimes boring industries can be home to the most attractive investments. That’s especially true in the small-cap world, where many companies haven’t yet reached their market potential. Such is the case with today’s tiny medical waste play.
Sharps Compliance (OTC: SMED ) is a provider of medical waste disposal solutions. The flagship product is the Sharps Disposal by Mail System. This product is simply a sealed, leak and puncture resistant container that allows medical waste to be mailed to a disposal center via the U.S. Postal Service or UPS. The waste is tracked electronically, allowing documentation of proper disposal.
Another important product for Sharps is their Medical Waste Management System, or MWMS. This is a comprehensive system designed to meet the waste disposal needs of the “alternate site market”, which simply refers to settings outside of the hospital. In general, MWMS is a package of services, including the Disposal by Mail System, and also inventory, training, data management, and other services that provide for a complete solution for entities such as emergency preparedness services.
The company sells to a wide variety of customers. The largest customer segment (36%) is home healthcare providers. Government makes up about 30% of sales, mostly for emergency services. Other customers include doctor’s offices, retail stores that administer flu shots, veterinarians, hotels, etc.
Sharps is not the typical “Magic Formula” stock. The elevated earnings yield (29%) and return on capital (298%) figures are due to the completion of a front-loaded contract with an undisclosed U.S. Government agency to deploy MWMS. Of the total contract value of $40 million, Sharps realized nearly $29 million in revenue over the most recent four quarters.
Compare this to the company’s total 2008 revenues of about $13 million, and it’s clear that we are looking at the one-time, non-recurring revenue issue that occasionally pops up. The remainder of the contract will work off over the next 4 years, providing anywhere from $1.6 to about $3 million in annual maintenance sales for Sharps.
It is instructive to take a look at the past four quarters while backing out this big $29 million windfall, while still allowing for the incremental contract value going forward.
If we do this, Sharps earned just over $17 million in sales, vs. a reported $44 million. In the most recent quarter, non-contract sales would have grown an impressive 45%. Figuring out a good operating margin is more difficult. Clearly there is a lot of leverage in the cost structure, as Sharps has posted 50%+ operating margins with those big contract sales. However, in the previous 5 years the company had difficulty even pulling a profit, with the average operating margin a paltry 5%.
If we use a generous 9% operating margin in this pro-forma evaluation, we come out with an earnings yield of 2.2% and a return on capital just over 20% – not impressive numbers. Against expected 2011 results, the stock has about a 7% earnings yield.
That said, Sharps is still worth a look for MFI investors. Sales are growing impressively under the one-time noise, and management believes they have over $20 million in pipeline deals with pharmaceutical makers alone. The government contract win led to both a supply schedule contract with the General Services Administration (GSA) of the U.S. Government, as well as a Distribution and Pricing Agreement (DAPA) with the Defense Department. These agreements effectively “grease the wheels” for more government work, a significant opportunity.
Almost immediately after these were announced, Sharps launched a pilot program with the Veteran’s Association (VA) to collect their medical waste in the Mid-Atlantic region. The regulatory environment is on Sharps’ side as well, with many states enacting or planning to enact tough laws governing the disposal of medical waste (which is often just put in the trash today). Growth potential is very strong, possibly explosive, and we’ve already seen how higher sales levels lead to much higher profit margins due to the firm’s fixed cost structure.
Two other positives are the firm’s financial health and executive team. The company has a market capitalization of just under $90 million, but has almost $22 million in cash on the balance sheet and no debt. The management team is led by founder Burton Kunik, and insiders own an impressive 60% of the outstanding shares. I love to see this in small-cap firms… It is a sign of dedication and focus, and aligns the priorities of management with those of its shareholders.
Let’s talk about the risks here. First, as mentioned, is the valuation. This is not really a cheap stock against forward-looking estimates. Sharps will have to continue to grow at a brisk pace, which I believe they can do.
Competition is a larger concern. Stericycle (NASDAQ: SRCL ), by far the largest medical waste disposal firm in the country, also has a mail-in program. Several smaller companies offer alternative solutions that allow on-site disposal. There are few barriers to entry.
All that is required to get a business like this up and running is a method of disposal (Sharps has their own incinerator) and some easily developed containers. Lastly, the common small-cap risk of customer concentration is a problem here as well. Just four customers account for about half of sales. Losing one of them would be material to results.
All-in-all, Sharps is an interesting company that presents growth-oriented investors an attractive entry point to the recession-resistant waste disposal market.
February 11, 2010
Article printed from Penny Sleuth: http://pennysleuth.com
URL to article: http://pennysleuth.com/this-small-medical-waste-company-offers-growth-right-now/
URLs in this post:
 NASDAQ: GOOG: http://www.google.com/finance?q=NASDAQ%3AGOOG
 NASDAQ: AAPL: http://www.google.com/finance?q=NASDAQ%3AAAPL
 OTC: SMED: http://www.google.com/finance?q=NASDAQ%3ASMED
 NASDAQ: SRCL: http://www.google.com/finance?q=NASDAQ%3ASRCL
 MagicDiligence.com: http://www.magicdiligence.com/
 The Perfect Time for an Imperfect Investment: http://pennysleuth.com/the-perfect-time-for-an-imperfect-investment/
 Four Breakout Penny Stock Charts for March: http://pennysleuth.com/four-breakout-penny-stock-charts-for-march/
 Two Aircraft Supply Stocks for 2010: http://pennysleuth.com/two-aircraft-supply-stocks-for-2010/
 Another Potentially Profitable China Penny Play: http://pennysleuth.com/another-potentially-profitable-china-penny-play/
 Why We Could See a 131% Gain on This Chinese Travel Firm: http://pennysleuth.com/why-we-could-see-a-131-gain-on-this-chinese-travel-firm/
Copyright © 2009 Penny Sleuth. All rights reserved.